What were the top pharma news stories as of February 2026? Three major pharmaceutical and health technology stories shaped coverage in January 2026: a legal challenge to revised U.S. childhood vaccine guidance, a high-profile AI partnership between Bristol Myers Squibb and Microsoft to improve lung cancer detection, and OpenEvidence’s presentation of an agentic AI–driven vision […]
What were the top pharma news stories in January 2026? Three major pharmaceutical news stories dominated December 2025: the Trump administration’s proposed overhaul of childhood vaccine recommendations, voluntary drug pricing agreements under the Most Favored Nation policy, and the FDA’s qualification of AIM-NASH, the first AI tool for MASH clinical trials. January 2026 Pharma News […]
Healthcare media coverage in October and November centers on regulatory tension, financial strain and shifting policy priorities across the U.S. News cycles focus on leadership disruption at the FDA, federal efforts to revise medical debt reporting rules and rising ACA premiums that place added pressure on households. These themes reflect ongoing concerns about affordability, oversight […]
This month’s healthcare and pharmaceutical coverage highlights how political decisions and emerging technologies are redefining access to care and public confidence in the system. From Trump’s initiatives on drug pricing, fertility access, and AI-driven cancer research to growing scrutiny of AI’s role in medical advice, the discussions reflect a sector balancing innovation with regulation and […]
This month’s healthcare and pharmaceutical coverage underscores the growing tensions between medical innovation, public policy, and patient safety. From the FDA’s shift in COVID-19 vaccine guidance to controversial political backing of unproven autism research, and the rise of AI-powered diagnostic tools such as smart stethoscopes, the industry is navigating a rapidly changing environment. These developments […]
This month’s healthcare and pharmaceutical coverage highlights how political pressure, regulatory changes, and new technologies are reshaping access to care and influencing public trust. From government action on drug pricing and funding cuts to HIV programs to debates over AI-driven health advice, the industry faces complex challenges at the intersection of innovation, affordability, and safety. […]
This month’s healthcare and pharmaceutical headlines reflect the growing influence of politics, corporate strategy, and innovation on public health. Limited FDA approval of some COVID vaccines, major acquisitions to expand treatment portfolios, and advances in AI-assisted fertility care show how decisions around access, investment, and technology are shaping the industry. These developments signal a shift […]
This month’s healthcare and pharmaceutical headlines reflect increased scrutiny of public health decisions, regulatory actions, and funding priorities. Changes in advisory panels, shifts in government spending, and the adoption of new technologies influence how treatments are approved, funded, and perceived. These developments underscore the growing intersection of science, politics, and public opinion. As healthcare policy […]
The pharmaceutical industry continues its rapid evolution in June 2025, with breakthrough approvals, global market expansions, and multi-billion-dollar acquisitions reshaping the healthcare landscape. These developments signal fundamental shifts in how we approach cancer treatment, weight management, and international health access, each presenting unique challenges and opportunities for communications professionals. 1. FDA Approves Datroway for Lung […]
May’s top healthcare stories highlight major shifts in drug pricing policies, data-driven health initiatives, and advances in genetic medicine. Public and media attention is focused on government-led cost reforms and growing concerns over transparency and ethics in healthcare research. At the same time, new developments in personalized medicine offer cautious optimism for rare disease treatment. […]
